Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisCompleted
NCT02922192N/AUpdated Jul 27, 2023
Sponsor: Biologics & Biosimilars Collective Intelligence Consortium
Rheumatoid Arthritis · Inflammatory Bowel Disease · Psoriasis · Psoriatic Arthritis
Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)Completed
NCT03036813Phase 3Updated Jul 27, 2023
Sponsor: Pfizer
Sickle Cell Disease
United States, Canada, Egypt, France, Italy +7 more
Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver EnzymesTerminated
NCT01226797Phase 2Updated Jul 27, 2023
Sponsor: Pfizer
Hepatitis C, Chronic
Hong Kong, India, Singapore, South Korea, Taiwan
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins LymphomaCompleted
NCT01614197Phase 1Updated Jul 27, 2023
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Lymphoblastic Leukemia, Acute, Childhood · Lymphoblastic Lymphoma · Peripheral T-cell Lymphoma
United States, Australia, Canada
A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy ParticipantsCompleted
NCT05036512Phase 1Updated Jul 25, 2023
Sponsor: Pfizer
Sickle Cell Disease
United States, Australia
PF-06669571 In Subjects With Idiopathic Parkinson's DiseaseCompleted
NCT02565628Phase 1Updated Jul 24, 2023
Sponsor: Pfizer
Idiopathic Parkinson's Disease
United States
Varenicline Pregnancy Cohort StudyCompleted
NCT01290445N/AUpdated Jul 24, 2023
Sponsor: Pfizer
Malformations
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic ImpairmentCompleted
NCT03114540Phase 1Updated Jul 18, 2023
Sponsor: Pfizer
Hepatic Impairment
United States
Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment OptionsNo Longer Available
NCT03943615N/AUpdated Jul 18, 2023
Sponsor: Pfizer
Sickle Cell Disease
United States
Statin Therapy for Ischemic and Nonischemic CardiomyopathyCompleted
NCT00701220Phase 4Updated Jul 18, 2023
Sponsor: Philip Binkley
Cardiovascular Disease · Cardiomyopathy · Heart Disease · Myocardial Disease
United States
miRNA as a Growth Plate Marker After GHUnknown
NCT05946915N/AUpdated Jul 14, 2023
Sponsor: Faculdade de Ciências Médicas da Santa Casa de São Paulo
MicroRNAs: D13.444.735.790.552.500
Brazil
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy ParticipantsCompleted
NCT04962022Phase 1Updated Jul 13, 2023
Sponsor: Pfizer
Healthy Participant
Belgium
A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial CancerTerminated
NCT05568407N/AUpdated Jul 13, 2023
Sponsor: Pfizer
Bladder Cancer
Argentina, Brazil
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of StrokeCompleted
NCT04126486Phase 4Updated Jul 12, 2023
Sponsor: Bristol-Myers Squibb
Atrial Fibrillation · Atrial Flutter
United States
Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)Completed
NCT03342690N/AUpdated Jul 11, 2023
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Chronic Heart Failure
Japan
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)Completed
NCT02580058Phase 3Updated Jul 10, 2023
Sponsor: Pfizer
Ovarian Cancer
United States, Australia, Austria, Belgium, Canada +20 more
Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe HemophiliaCompleted
NCT04878731Phase 1Updated Jul 7, 2023
Sponsor: Pfizer
Severe Hemophilia
China
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.Completed
NCT04267614N/AUpdated Jul 7, 2023
Sponsor: Pfizer
Arthritis Rheumatoid
Iraq
Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)Terminated
NCT02584634Phase 1, Phase 2Updated Jul 7, 2023
Sponsor: Pfizer
Non-Small Cell Lung Cancer
United States, Australia, Japan, South Korea, Spain
Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease SubjectsCompleted
NCT00810732Phase 2Updated Jul 6, 2023
Sponsor: Pfizer
Chronic Kidney Disease
United Kingdom
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaCompleted
NCT03991884Phase 1Updated Jul 6, 2023
Sponsor: University of Washington
Recurrent B Acute Lymphoblastic Leukemia · Recurrent B Lymphoblastic Lymphoma · Refractory B Acute Lymphoblastic Leukemia · Refractory B Lymphoblastic Lymphoma
United States
Metformin Use to Reduce Disparities in Newly Diagnosed Breast CancerWithdrawn
NCT04741204Phase 4Updated Jul 6, 2023
Sponsor: Woman's
Breast Cancer Stage · Insulin Resistance · Racial Bias
United States
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown OriginCompleted
NCT05038982Phase 2Updated Jul 3, 2023
Sponsor: Johns Hopkins University
Prurigo Nodularis · Pruritus · Chronic Pruritus · Chronic Prurigo
United States
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type FibromatosisCompleted
NCT01265030Phase 1, Phase 2Updated Jun 26, 2023
Sponsor: MaineHealth
Desmoid Tumor
United States
Comorbidities And Reducing inEquitieSCompleted
NCT04836221NAUpdated Jun 18, 2023
Sponsor: Medstar Health Research Institute
Cancer, Breast · Diabetes Mellitus · Hypertension · Cancer Prostate
United States

Previous page Next page